Research and Markets: Research Report: Namenda XR (Alzheimer's Disease) - Forecast and Market Analysis to 2022

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/jc3gch/namenda_xr) has announced the addition of the "Namenda XR (Alzheimer's Disease) - Forecast and Market Analysis to 2022" report to their offering.

PharmaPoint Drug Evaluation report, Namenda XR (Alzheimer's Disease) - Forecast and Market Analysis to 2022. There are no long-term effective therapies for Alzheimer's Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.

Namenda XR is a once-daily, controlled-release formulation of memantine hydrochloride, an NMDA receptor antagonist that is indicated for the treatment of moderate to severe AD dementia. The ER formulation is designed to simplify the complicated therapies that are often used in patients in the advanced AD stages.

Scope

- Overview of AD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on Namenda XR including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for Namenda XR for the top one country from 2012 to 2022.

- Sales information covered for the US.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of the competition by understanding the changing competitive landscape for AD

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of Namenda XR performance

- Obtain sales forecast for Namenda XR from 2012-2022 in top one country (the US)

For more information visit http://www.researchandmarkets.com/research/jc3gch/namenda_xr

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System